Cutaneous Manifestations of Neglected Infectious Diseases in US Military Personnel

Article Type
Article
Changed
Display Headline

Cutaneous Manifestations of Neglected Infectious Diseases in US Military Personnel

IN PARTNERSHIP WITH THE ASSOCIATION OF MILITARY DERMATOLOGISTS
Author(s)
Kolby Quillin, BA
Guilherme Kuceki, MD
Peter Seline, MD

Infectious diseases historically have posed major challenges to the operations and health of military forces. In recent conflicts, nonbattle injuries including infections have caused more evacuations than combat trauma.1 Deployment to endemic regions, poor sanitation, and trauma increase susceptibility to both common and rare infections, many of which have cutaneous manifestations.

Surveillance programs such as the Armed Forces Health Surveillance Division serve a critical role in monitoring outbreaks among deployed personnel.2 Cutaneous manifestations of systemic disease often serve as early clinical indicators, especially in settings with limited diagnostic resources. This review describes rarely encountered infectious agents for which US military personnel are at increased risk and outlines management strategies for clinicians practicing in austere environments.

EPIDEMIOLOGIC RISK FACTORS IN MILITARY POPULATIONS

United States military personnel face an elevated risk for infectious diseases when deployed in tropical and subtropical regions where endemic pathogens are prevalent. Exposure to soil, water, and insect vectors facilitates transmission. Direct exposure during combat or training combined with high-density housing, combat-related trauma, and constraints on hygiene access during operations increases infection risk.3

REGION-SPECIFIC PATHOGENS

Middle East

Leishmania species—Leishmania, a protozoa transmitted via sand fly bites, has caused multiple documented outbreaks among US troops in Iraq and Afghanistan, with a reported incidence of 14%.4 Leishmaniasis can present as 3 main clinical variants: cutaneous, visceral, and mucocutaneous. Cutaneous leishmaniasis typically manifests as painless ulcers covered with hemorrhagic crusts on exposed regions of the body. While typically self-limited, lesions frequently result in irreversible scarring. Many Leishmania species respond well to antimonials such as sodium stibogluconate. Preventive measures include wearing protective clothing and sleeping inside insecticide-treated bed nets.5

Coxiella burnetii—Coxiella burnetii transmits through inhalation of aerosolized particles originating from the urine, feces, birth products, or milk of infected bovine. In 2003, a small number of cases were identified in US service members exposed to livestock while serving in Iraq.6 Outbreaks also occurred during World War II, but it is unclear whether they were caused by naturally occurring C burnetii or biowarfare.7 Though primarily a systemic illness with severe pneumonia, Q fever may manifest with an associated purpuric or morbilliform rash.8 Doxycycline is recommended both for treatment and empiric coverage.6

Acinetobacter baumannii—This multidrug-resistant organism is known to infect combat wounds and is associated with nosocomial outbreaks in military hospitals. Studies suggest environmental contamination and health care transmission contribute substantially to outbreaks in military hospitals.9 Cutaneous manifestations can include cellulitis with a peau d’orange appearance or necrotizing fasciitis; however, pneumonia and bacteremia have been reported. Prompt culture and antibiotic initiation with debridement are essential for treatment.10 Antibiotic stewardship and strict infection control are critical to prevent outbreaks and limit resistance.9

Africa

Plasmodium species—Malaria remains a life-threatening disease found in tropical and subtropical areas around the world. Despite preventive measures, 30 cases among US service members were reported in 2024.11 Cutaneous findings include purpura fulminans, petechiae, acral necrosis, or reticulated erythema.12 Service members stationed in endemic areas should take prophylactic antimalarials. Symptoms include fevers, headaches, and malaise, with possible rapid deterioration.13

Mycobacterium ulcerans—Mycobacterium ulcerans causes extensive necrotic ulcers—commonly known as Buruli ulcers—which generally begin as a nodule, plaque, papule, or edematous lesion, eventually progressing to extensive ulceration. Despite no documented cases of US personnel contracting Buruli ulcers, those stationed in endemic regions remain at risk. Environmental reservoirs of M ulcerans are unknown, but its DNA has been isolated from water sources.14,15 These ulcers take months to heal, making wound management and antimycobacterial therapy essential. Primary preventive measures include avoidance of swimming in rivers or agricultural work in endemic areas.14

Mpox Virus—During the 2022 mpox outbreak, male service members who engaged in sexual activity with other men were at the highest risk, with 88.8% of infected service members reporting this practice.16 While the virus is endemic to Africa, 89.0% of cases were reported from service members stationed in the United States.17 Typical infection results in fever, headache, lymphadenopathy, and myalgias, followed by a facial rash that spreads over the body, palms, and soles. Safe-sex practices help prevent transmission, and there is a vaccine available for high-risk patients.16

Southeast Asia

Leptospira species—Leptospira is an aerobic spirochete found in tropical regions worldwide. Transmission occurs when water contaminated with urine from infected animals exposes humans to the organism. Infection manifests as a mild febrile illness, though approximately 10% of patients develop Weil syndrome, consisting of conjunctival suffusion, jaundice, and acute kidney injury. Treatment and prophylaxis include doxycycline, but severe disease warrants intravenous antibiotics.17,18 A 2014 outbreak among Marines in Japan highlighted poor prophylactic compliance as a key risk factor.19 Proper education for those at risk is essential to prevent future outbreaks.

Mycobacterium leprae—Leprosy is an acid-fast mycobacterium that remains endemic in the Pacific Islands and Southeast Asia. Case reports of US service members diagnosed with leprosy exist, though only in patients who emigrated from endemic areas.20 This disease has a spectrum of manifestations depending on the immune response, with tuberculoid leprosy showing a ­cell-mediated (T helper 1) response and lepromatous leprosy having more of a humoral (T helper 2) response.21 It manifests with hypopigmented anesthetic macules and peripheral neuropathy. Diagnosis is made by skin biopsy, which shows perineural lymphohistiocytic inflammation and non-necrotizing granulomas.20 The infection typically is curable with a multidrug regimen.21

Strongyloides stercoralis—This nematode causes infection by transdermal penetration of bare feet. They then migrate to the lungs where the patient coughs and swallows the nematode into the gastrointestinal tract. Strongyloides stercoralis autoinfect by penetrating the intestinal wall, resulting in chronic digestive, respiratory, and cutaneous symptoms. Worldwide prevalence of S stercoralis infection is estimated to be 10% to 40%, with foreign-born US military members at increased risk compared to the general military population.22,23 Larva currens may manifest with a pruritic erythematous plaque at the site of penetration that progresses to an intensely pruritic, creeping dermatitis as the nematode migrates under the skin. Avoidance of barefoot soil exposure and treatment with ivermectin are effective preventive and therapeutic measures.23

South America

Ancylostoma braziliense—Found throughout the subtropical world, this hookworm primarily infects dogs and cats and is found in their stool. Larva currens has a similar manifestation and life cycle to cutaneous larva migrans, but autoinfection does not occur. Transmission occurs similarly to S stercoralis and responds well to oral albendazole or ivermectin; however, the infection is self-limited.24 Military cases have been reported,25 though overall morbidity remains poorly characterized.

Dengue Virus—An arbovirus transmitted by Aedes mosquitoes, dengue remains a major military threat. Service members in the Vietnam War experienced an attack rate as high as 80%.26,27 Infection often manifests with retro-orbital pain and a morbilliform rash that occurs 2 to 5 days after fever, though severe cases may progress to hemorrhagic dengue with skin petechiae or ecchymosis.28 Immediate intervention is essential in symptomatic patients to prevent life-threatening progression. There are no dengue vaccines approved by the US Food and Drug Administration for adults, thus military personnel in endemic areas remain at risk.27

Trypanosoma cruzi—Chagas disease is transmitted when a reduviid infected with T cruzi bites and defecates on the patient’s skin. A skin nodule (chagoma) or painless eyelid edema (Romaña sign) may appear at the site of parasite entry. Chronic disease may result in dilated cardiomyopathy.29 Several cases of Chagas disease have been reported in South American military operations, including an outbreak in 9 Columbian military personnel.30 Cases in the southwestern United States have recently emerged, emphasizing the need for increased awareness.31 Proper insect repellent helps to ward off reduviid bugs. Nifurtimox and benznidazole are the only drugs with proven efficacy against T cruzi.29

Continental United States of America

Coccidioides immitis—The first reported case of coccidiomycosis was described in 1892 in a service member with debilitating masses and ulcers.32 Endemic to arid regions of the western United States, coccidioidomycosis affects military trainees at rates up to 32% annually in high-risk settings.33 Primary infection occurs in the lungs and may spread hematologically. The fungi prefer dry desert soils, which may aerosolize during military maneuvers. Coccidioidomycosis occasionally causes erythema nodosum, and diffuse infection shows verrucous plaques, ulcers, or abscesses. Dust avoidance and mask wearing are advised for those in endemic regions. Ketoconazole and amphotericin B are the only treatments approved by the US Food and Drug Administration.32 When starting immunosuppressive drugs, clinicians should inquire if patients have previously been stationed in Coccidioides-endemic areas, such as Fort Irwin, California, to avoid reactivation of the fungi.33

Francisella tularensis—Acquired via ticks or contact with wild animals, tularemia causes an ulceroglandular disease with regional lymphadenopathy. Inoculation requires as few as 10 to 25 organisms; thus it is considered a Category A agent for bioterror.34 Natural outbreaks have occurred during war times, most recently during the civil wars in Bosnia and Kosovo.35 Patients may present with a painful ulcer that enlarges to form a plaque with raised borders. Personnel in wooded areas should use tick precautions and handle wild animals cautiously. Treatment includes gentamicin for severe disease, with tetracyclines effective in mild cases.34

PREVENTION AND MANAGEMENT STRATEGIES IN AUSTERE SETTINGS

For health care professionals practicing in military settings, austere environments can provide a challenge for diagnosis of neglected diseases. Despite a lack of advanced diagnostic tools, practical options can be applied to the diagnostic process; for example, teledermatology is utilized for treatment of service members deployed to remote environments.36

Management of uncommon infectious diseases in military personnel often requires treatments outside those practiced in domestic clinics. Field management may indicate prompt empiric therapy while balancing the risks of overtreatment against those of missed diagnoses37; however, medical evacuation to a higher level of care may be indicated in patients with severe presentations to expedite diagnosis and treatment.38

Prevention remains the primary goal to avoid local outbreaks. Long-sleeved uniforms, DEET (N, ­N-diethyl-meta-toluamide)–based repellents, permethrin-impregnated clothing, and bed nets are effective for vector protection. Prophylactic medications and vaccinations often are provided when personnel are deployed to endemic locations.39

Onsite entomology teams also can provide surveillance of the local insect populations. They may contribute to vector control through insecticide application and environmental modification. The Armed Forces Health Surveillance Division and the Global Emerging Infections Surveillance Program monitor infectious threats in real time to locate any potential outbreaks, guiding operational responses.40

FINAL THOUGHTS

Dermatologic signs often provide early evidence of infection in military personnel. With increasing antimicrobial resistance and the emergence of new pathogens, it is imperative for clinicians treating members of the military to recognize cutaneous signs, employ efficient diagnostic strategies, and encourage proactive prevention. A collaborative approach spanning dermatology, infectious disease, and public health is essential to protect the modern service member.

References
  1. Murray CK. Infectious disease complications of combat-related injuries. Crit Care Med. 2008;36(7 suppl):S358-S364. doi:10.1097/CCM.0b013e31817e2ffc
  2. Armed Forces Health Surveillance Division. AFHSD Annual Report. Defense Health Agency; 2023. Accessed March 5, 2026. https://www.health.mil/Reference-Center/Reports/2024/09/19/AFHSD-Annual-Report-2023
  3. Murray CK, Yun HC, Markelz AE, et al. Operation United Assistance: infectious disease threats to deployed military personnel. Military Medicine. 2015;180:626-651. doi:10.7205/MILMED-D-14-00691
  4. Niba Rawlings N, Bailey M, Courtenay O. Leishmaniasis in deployed military populations: a systematic review and meta-analysis. PLoS Negl Trop Dis. 2025;19:E0012680. doi:10.1371/journal.pntd.0012680
  5. de Vries HJC, Schallig HD. Cutaneous leishmaniasis: a 2022 updated narrative review into diagnosis and management developments. Am J Clin Dermatol. 2022;23:823-840. doi:10.1007/s40257-022-00726-8
  6. Anderson AD, Smoak B, Shuping E, et al. Q fever and the US military. Emerg Infect Dis. 2005;11:1320-1322. doi:10.3201/eid1108.050314
  7. Madariaga MG, Rezai K, Trenholme GM, et al. Q fever: a biological weapon in your backyard. Lancet Infect Dis. 2003;3:709-721. doi:10.1016/S1473-3099(03)00804-1
  8. Uribe Pulido N, Escorcia García C, Cabrera Orrego R, et al. Acute Q fever with dermatologic manifestations, molecular diagnosis, and no seroconversion. Open Forum Infect Dis. 2021;8:ofab458. doi:10.1093/ofid/ofab458
  9. Scott P, Deye G, Srinivasan A, et al. An outbreak of multidrug-resistant acinetobacter baumannii-calcoaceticus complex infection in the US Military Health Care System associated with military operations in Iraq. Clin Infect Dis. 2007;44:1577-1584. doi:10.1086/518170
  10. Guerrero DM, Perez F, Conger NG, et al. Acinetobacter baumannii-associated skin and soft tissue infections: recognizing a broadening spectrum of disease. Surg Infect (Larchmt). 2010;11:49-57. doi:10.1089/sur.2009.022
  11. Armed Forces Health Surveillance Division. Malaria among members of the US Armed Forces, 2024. MSMR. 2025;32:22-28.
  12. Farkouh CS, Abdi P, Amatul-Hadi F, et al. Cutaneous manifestations of malaria and their prognostic windows: a narrative review. Cureus. 2023;15:E41706. doi:10.7759/cureus.41706
  13. Shahbodaghi SD, Rathjen NA. Malaria: prevention, diagnosis, and treatment. Am Fam Physician. 2022;106:270-278.
  14. Yotsu RR, Suzuki K, Simmonds RE, et al. Buruli ulcer: a review of the current knowledge. Curr Trop Med Rep. 2018;5:247-256. doi:10.1007/s40475-018-0166-2
  15. Portaels F, Meyers WM, Ablordey A, et al. First cultivation and characterization of Mycobacterium ulcerans from the environment. PLoS Negl Trop Dis. 2008;2:E178. doi:10.1371/journal.pntd.0000178
  16. Metcalf-Kelly M, Garrison M, Stidham R. Characteristics of mpox cases diagnosed in Military Health System beneficiaries, May 2022-April 2024. MSMR. 2024;31:7-11.
  17. Rajapakse S. Leptospirosis: clinical aspects. Clin Med (Lond). 2022;22:14-17. doi:10.7861/clinmed.2021-0784
  18. Heath CW, Alexander AD, Galton MM. Leptospirosis in the United States: a of 483 cases in man, 1949–1961. N Engl J Med. 1965;273:857-864. doi:10.1056/NEJM196510142731606
  19. Mason V. Mystery outbreak investigation 2014—Leptospirosis licerasiae. November 17, 2017. Accessed March 5, 2026. https://usupulse.blogspot.com/2017/11/mystery-outbreak-investigation-2014.html
  20. Berjohn CM, DuPlessis CA, Tieu K, et al. Multibacillary leprosy in an active duty military member. Emerg Infect Dis. 2015;21:1077-1078. doi:10.3201/eid2106.141666
  21. Scollard DM, Adams LB, Gillis TP, et al. The continuing challenges of leprosy. Clin Microbiol Rev. 2006;19:338-381. doi:10.1128/CMR.19.2.338-381.2006
  22. Schär F, Trostdorf U, Giardina F, et al. Strongyloides stercoralis: global distribution and risk factors. PLoS Negl Trop Dis. 2013;7:E2288. doi:10.1371/journal.pntd.0002288
  23. Taheri B, Kuo HC, Hockenbury N, et al. Strongyloides stercoralis in the US Military Health System. Open Forum Infect Dis. 2023;10:ofad127. doi:10.1093/ofid/ofad127
  24. Bowman DD, Montgomery SP, Zajac AM, et al. Hookworms of dogs and cats as agents of cutaneous larva migrans. Trends Parasitol. 2010;26:162-167. doi:10.1016/j.pt.2010.01.005
  25. Inglis DM, Bailey MS. Unusual presentations of cutaneous larva migrans in British military personnel. BMJ Mil Health. 2023;169:E78-E81. doi:10.1136/bmjmilitary-2020-001677
  26. Halstead SB, Udomsakdi S, Singharaj P, et al. Dengue and chikungunya virus infection in man in Thailand, 1962–1964. 3. clinical, epidemiologic, and virologic observations on disease in non-indigenous white persons. Am J Trop Med Hyg. 1969;18:984-996. doi:10.4269/ajtmh.1969.18.984
  27. Gibbons RV, Streitz M, Babina T, et al. Dengue and US military operations from the Spanish-American War through today. Emerg Infect Dis. 2012;18:623-630. doi:10.3201/eid1804.110134
  28. Guzman MG, Harris E. Dengue. Lancet. 2015;385:453-465. doi:10.1016/S0140-6736(14)60572-9
  29. Bern C. Chagas’ disease. N Engl J Med. 2015;373:456-466. doi:10.1056/NEJMra1410150
  30. Vergara HD, Gómez CH, Faccini-Martínez ÁA, et al. Acute Chagas disease outbreak among military personnel, Colombia, 2021. Emerg Infect Dis. 2023;29:1882-1885. doi:10.3201/eid2909.230886
  31. Harris N, Woc-Colburn L, Gunter SM, et al. Autochthonous Chagas disease in the southern United States: a case report of suspected residential and military exposures. Zoonoses Public Health. 2017;64:491-493. doi:10.1111/zph.12360
  32. Crum NF. Coccidioidomycosis: a contemporary review. Infect Dis Ther. 2022;11:713-742. doi:10.1007/s40121-022-00606-y
  33. Crum NF, Potter M, Pappagianis D. Seroincidence of coccidioidomycosis during military desert training exercises. J Clin Microbiol. 2004;42:4552-4555. doi:10.1128/JCM.42.10.4552-4555.2004
  34. Antonello RM, Giacomelli A, Riccardi N. Tularemia for clinicians: an up-to-date review on epidemiology, diagnosis, prevention and treatment. Eur J Intern Med. 2025;135:25-32. doi:10.1016/j.ejim.2025.03.013
  35. Nelson CA, Sjöstedt A. Tularemia: a storied history, an ongoing threat. Clin Infect Dis. 2024;78(supplement_1):S1-S3. doi:10.1093/cid/ciad681
  36. Pendlebury GA, Roman J, Shrivastava V, et al. A call to action: evidence for the military integration of teledermoscopy in a pandemic era. Dermatopathology (Basel). 2022;9:327-342. doi:10.3390/dermatopathology9040039
  37. Bhagchandani R, Singhi S, Peter JV, et al. Tropical fevers: management guidelines. Indian J Crit Care Med. 2014;18:62-69. doi:10.4103/0972-5229.126074
  38. Joint Chiefs of Staff. Joint Publication 4-02: Joint Health Services. December 11, 2017. Accessed March 5, 2026. https://cdmrp.health.mil/pubs/pdf/Joint%20Health%20Services%20Publication%20JP%204-02.pdf
  39. Armed Services Pest Management Board. Technical Guide No. 36: Personal Protective Measures Against Insects and Other Arthropods of Military Significance. Updated November 2015. Accessed March 5, 2026. https://www.acq.osd.mil/eie/afpmb/docs/techguides/tg36.pdf
  40. Global Emerging Infections Surveillance. Armed Forces Health Surveillance Division Annual Report 2024. Defense Health Agency; 2024:15-28. Accessed March 17, 2026. https://www.health.mil/Reference-Center/Reports/2026/01/05/AFHSD-Annual-Report-2024
Article PDF
CT117004118.pdf
Author and Disclosure Information

Kolby Quillin is from the University of Toledo College of Medicine and Life Sciences, Ohio. Dr. Kuceki is from the Department of Dermatology, Ohio Health Riverside, Columbus. Dr. Seline is from the Center for Surgical Dermatology, Westerville, Ohio.

The authors have no relevant financial disclosures to report.

Correspondence: Kolby Quillin, BA ([email protected]).

Cutis. 2026 April;117(4):118-121. doi:10.12788/cutis.1373

Issue
Cutis - 117(4)
Publications
Cutis
MDedge Dermatology
Topics
Infectious Diseases
Page Number
118-121
Sections
Military Dermatology
Author(s)
Kolby Quillin, BA
Guilherme Kuceki, MD
Peter Seline, MD
Author(s)
Kolby Quillin, BA
Guilherme Kuceki, MD
Peter Seline, MD
Author and Disclosure Information

Kolby Quillin is from the University of Toledo College of Medicine and Life Sciences, Ohio. Dr. Kuceki is from the Department of Dermatology, Ohio Health Riverside, Columbus. Dr. Seline is from the Center for Surgical Dermatology, Westerville, Ohio.

The authors have no relevant financial disclosures to report.

Correspondence: Kolby Quillin, BA ([email protected]).

Cutis. 2026 April;117(4):118-121. doi:10.12788/cutis.1373

Author and Disclosure Information

Kolby Quillin is from the University of Toledo College of Medicine and Life Sciences, Ohio. Dr. Kuceki is from the Department of Dermatology, Ohio Health Riverside, Columbus. Dr. Seline is from the Center for Surgical Dermatology, Westerville, Ohio.

The authors have no relevant financial disclosures to report.

Correspondence: Kolby Quillin, BA ([email protected]).

Cutis. 2026 April;117(4):118-121. doi:10.12788/cutis.1373

Article PDF
CT117004118.pdf
Article PDF
CT117004118.pdf
IN PARTNERSHIP WITH THE ASSOCIATION OF MILITARY DERMATOLOGISTS
IN PARTNERSHIP WITH THE ASSOCIATION OF MILITARY DERMATOLOGISTS

Infectious diseases historically have posed major challenges to the operations and health of military forces. In recent conflicts, nonbattle injuries including infections have caused more evacuations than combat trauma.1 Deployment to endemic regions, poor sanitation, and trauma increase susceptibility to both common and rare infections, many of which have cutaneous manifestations.

Surveillance programs such as the Armed Forces Health Surveillance Division serve a critical role in monitoring outbreaks among deployed personnel.2 Cutaneous manifestations of systemic disease often serve as early clinical indicators, especially in settings with limited diagnostic resources. This review describes rarely encountered infectious agents for which US military personnel are at increased risk and outlines management strategies for clinicians practicing in austere environments.

EPIDEMIOLOGIC RISK FACTORS IN MILITARY POPULATIONS

United States military personnel face an elevated risk for infectious diseases when deployed in tropical and subtropical regions where endemic pathogens are prevalent. Exposure to soil, water, and insect vectors facilitates transmission. Direct exposure during combat or training combined with high-density housing, combat-related trauma, and constraints on hygiene access during operations increases infection risk.3

REGION-SPECIFIC PATHOGENS

Middle East

Leishmania species—Leishmania, a protozoa transmitted via sand fly bites, has caused multiple documented outbreaks among US troops in Iraq and Afghanistan, with a reported incidence of 14%.4 Leishmaniasis can present as 3 main clinical variants: cutaneous, visceral, and mucocutaneous. Cutaneous leishmaniasis typically manifests as painless ulcers covered with hemorrhagic crusts on exposed regions of the body. While typically self-limited, lesions frequently result in irreversible scarring. Many Leishmania species respond well to antimonials such as sodium stibogluconate. Preventive measures include wearing protective clothing and sleeping inside insecticide-treated bed nets.5

Coxiella burnetii—Coxiella burnetii transmits through inhalation of aerosolized particles originating from the urine, feces, birth products, or milk of infected bovine. In 2003, a small number of cases were identified in US service members exposed to livestock while serving in Iraq.6 Outbreaks also occurred during World War II, but it is unclear whether they were caused by naturally occurring C burnetii or biowarfare.7 Though primarily a systemic illness with severe pneumonia, Q fever may manifest with an associated purpuric or morbilliform rash.8 Doxycycline is recommended both for treatment and empiric coverage.6

Acinetobacter baumannii—This multidrug-resistant organism is known to infect combat wounds and is associated with nosocomial outbreaks in military hospitals. Studies suggest environmental contamination and health care transmission contribute substantially to outbreaks in military hospitals.9 Cutaneous manifestations can include cellulitis with a peau d’orange appearance or necrotizing fasciitis; however, pneumonia and bacteremia have been reported. Prompt culture and antibiotic initiation with debridement are essential for treatment.10 Antibiotic stewardship and strict infection control are critical to prevent outbreaks and limit resistance.9

Africa

Plasmodium species—Malaria remains a life-threatening disease found in tropical and subtropical areas around the world. Despite preventive measures, 30 cases among US service members were reported in 2024.11 Cutaneous findings include purpura fulminans, petechiae, acral necrosis, or reticulated erythema.12 Service members stationed in endemic areas should take prophylactic antimalarials. Symptoms include fevers, headaches, and malaise, with possible rapid deterioration.13

Mycobacterium ulcerans—Mycobacterium ulcerans causes extensive necrotic ulcers—commonly known as Buruli ulcers—which generally begin as a nodule, plaque, papule, or edematous lesion, eventually progressing to extensive ulceration. Despite no documented cases of US personnel contracting Buruli ulcers, those stationed in endemic regions remain at risk. Environmental reservoirs of M ulcerans are unknown, but its DNA has been isolated from water sources.14,15 These ulcers take months to heal, making wound management and antimycobacterial therapy essential. Primary preventive measures include avoidance of swimming in rivers or agricultural work in endemic areas.14

Mpox Virus—During the 2022 mpox outbreak, male service members who engaged in sexual activity with other men were at the highest risk, with 88.8% of infected service members reporting this practice.16 While the virus is endemic to Africa, 89.0% of cases were reported from service members stationed in the United States.17 Typical infection results in fever, headache, lymphadenopathy, and myalgias, followed by a facial rash that spreads over the body, palms, and soles. Safe-sex practices help prevent transmission, and there is a vaccine available for high-risk patients.16

Southeast Asia

Leptospira species—Leptospira is an aerobic spirochete found in tropical regions worldwide. Transmission occurs when water contaminated with urine from infected animals exposes humans to the organism. Infection manifests as a mild febrile illness, though approximately 10% of patients develop Weil syndrome, consisting of conjunctival suffusion, jaundice, and acute kidney injury. Treatment and prophylaxis include doxycycline, but severe disease warrants intravenous antibiotics.17,18 A 2014 outbreak among Marines in Japan highlighted poor prophylactic compliance as a key risk factor.19 Proper education for those at risk is essential to prevent future outbreaks.

Mycobacterium leprae—Leprosy is an acid-fast mycobacterium that remains endemic in the Pacific Islands and Southeast Asia. Case reports of US service members diagnosed with leprosy exist, though only in patients who emigrated from endemic areas.20 This disease has a spectrum of manifestations depending on the immune response, with tuberculoid leprosy showing a ­cell-mediated (T helper 1) response and lepromatous leprosy having more of a humoral (T helper 2) response.21 It manifests with hypopigmented anesthetic macules and peripheral neuropathy. Diagnosis is made by skin biopsy, which shows perineural lymphohistiocytic inflammation and non-necrotizing granulomas.20 The infection typically is curable with a multidrug regimen.21

Strongyloides stercoralis—This nematode causes infection by transdermal penetration of bare feet. They then migrate to the lungs where the patient coughs and swallows the nematode into the gastrointestinal tract. Strongyloides stercoralis autoinfect by penetrating the intestinal wall, resulting in chronic digestive, respiratory, and cutaneous symptoms. Worldwide prevalence of S stercoralis infection is estimated to be 10% to 40%, with foreign-born US military members at increased risk compared to the general military population.22,23 Larva currens may manifest with a pruritic erythematous plaque at the site of penetration that progresses to an intensely pruritic, creeping dermatitis as the nematode migrates under the skin. Avoidance of barefoot soil exposure and treatment with ivermectin are effective preventive and therapeutic measures.23

South America

Ancylostoma braziliense—Found throughout the subtropical world, this hookworm primarily infects dogs and cats and is found in their stool. Larva currens has a similar manifestation and life cycle to cutaneous larva migrans, but autoinfection does not occur. Transmission occurs similarly to S stercoralis and responds well to oral albendazole or ivermectin; however, the infection is self-limited.24 Military cases have been reported,25 though overall morbidity remains poorly characterized.

Dengue Virus—An arbovirus transmitted by Aedes mosquitoes, dengue remains a major military threat. Service members in the Vietnam War experienced an attack rate as high as 80%.26,27 Infection often manifests with retro-orbital pain and a morbilliform rash that occurs 2 to 5 days after fever, though severe cases may progress to hemorrhagic dengue with skin petechiae or ecchymosis.28 Immediate intervention is essential in symptomatic patients to prevent life-threatening progression. There are no dengue vaccines approved by the US Food and Drug Administration for adults, thus military personnel in endemic areas remain at risk.27

Trypanosoma cruzi—Chagas disease is transmitted when a reduviid infected with T cruzi bites and defecates on the patient’s skin. A skin nodule (chagoma) or painless eyelid edema (Romaña sign) may appear at the site of parasite entry. Chronic disease may result in dilated cardiomyopathy.29 Several cases of Chagas disease have been reported in South American military operations, including an outbreak in 9 Columbian military personnel.30 Cases in the southwestern United States have recently emerged, emphasizing the need for increased awareness.31 Proper insect repellent helps to ward off reduviid bugs. Nifurtimox and benznidazole are the only drugs with proven efficacy against T cruzi.29

Continental United States of America

Coccidioides immitis—The first reported case of coccidiomycosis was described in 1892 in a service member with debilitating masses and ulcers.32 Endemic to arid regions of the western United States, coccidioidomycosis affects military trainees at rates up to 32% annually in high-risk settings.33 Primary infection occurs in the lungs and may spread hematologically. The fungi prefer dry desert soils, which may aerosolize during military maneuvers. Coccidioidomycosis occasionally causes erythema nodosum, and diffuse infection shows verrucous plaques, ulcers, or abscesses. Dust avoidance and mask wearing are advised for those in endemic regions. Ketoconazole and amphotericin B are the only treatments approved by the US Food and Drug Administration.32 When starting immunosuppressive drugs, clinicians should inquire if patients have previously been stationed in Coccidioides-endemic areas, such as Fort Irwin, California, to avoid reactivation of the fungi.33

Francisella tularensis—Acquired via ticks or contact with wild animals, tularemia causes an ulceroglandular disease with regional lymphadenopathy. Inoculation requires as few as 10 to 25 organisms; thus it is considered a Category A agent for bioterror.34 Natural outbreaks have occurred during war times, most recently during the civil wars in Bosnia and Kosovo.35 Patients may present with a painful ulcer that enlarges to form a plaque with raised borders. Personnel in wooded areas should use tick precautions and handle wild animals cautiously. Treatment includes gentamicin for severe disease, with tetracyclines effective in mild cases.34

PREVENTION AND MANAGEMENT STRATEGIES IN AUSTERE SETTINGS

For health care professionals practicing in military settings, austere environments can provide a challenge for diagnosis of neglected diseases. Despite a lack of advanced diagnostic tools, practical options can be applied to the diagnostic process; for example, teledermatology is utilized for treatment of service members deployed to remote environments.36

Management of uncommon infectious diseases in military personnel often requires treatments outside those practiced in domestic clinics. Field management may indicate prompt empiric therapy while balancing the risks of overtreatment against those of missed diagnoses37; however, medical evacuation to a higher level of care may be indicated in patients with severe presentations to expedite diagnosis and treatment.38

Prevention remains the primary goal to avoid local outbreaks. Long-sleeved uniforms, DEET (N, ­N-diethyl-meta-toluamide)–based repellents, permethrin-impregnated clothing, and bed nets are effective for vector protection. Prophylactic medications and vaccinations often are provided when personnel are deployed to endemic locations.39

Onsite entomology teams also can provide surveillance of the local insect populations. They may contribute to vector control through insecticide application and environmental modification. The Armed Forces Health Surveillance Division and the Global Emerging Infections Surveillance Program monitor infectious threats in real time to locate any potential outbreaks, guiding operational responses.40

FINAL THOUGHTS

Dermatologic signs often provide early evidence of infection in military personnel. With increasing antimicrobial resistance and the emergence of new pathogens, it is imperative for clinicians treating members of the military to recognize cutaneous signs, employ efficient diagnostic strategies, and encourage proactive prevention. A collaborative approach spanning dermatology, infectious disease, and public health is essential to protect the modern service member.

Infectious diseases historically have posed major challenges to the operations and health of military forces. In recent conflicts, nonbattle injuries including infections have caused more evacuations than combat trauma.1 Deployment to endemic regions, poor sanitation, and trauma increase susceptibility to both common and rare infections, many of which have cutaneous manifestations.

Surveillance programs such as the Armed Forces Health Surveillance Division serve a critical role in monitoring outbreaks among deployed personnel.2 Cutaneous manifestations of systemic disease often serve as early clinical indicators, especially in settings with limited diagnostic resources. This review describes rarely encountered infectious agents for which US military personnel are at increased risk and outlines management strategies for clinicians practicing in austere environments.

EPIDEMIOLOGIC RISK FACTORS IN MILITARY POPULATIONS

United States military personnel face an elevated risk for infectious diseases when deployed in tropical and subtropical regions where endemic pathogens are prevalent. Exposure to soil, water, and insect vectors facilitates transmission. Direct exposure during combat or training combined with high-density housing, combat-related trauma, and constraints on hygiene access during operations increases infection risk.3

REGION-SPECIFIC PATHOGENS

Middle East

Leishmania species—Leishmania, a protozoa transmitted via sand fly bites, has caused multiple documented outbreaks among US troops in Iraq and Afghanistan, with a reported incidence of 14%.4 Leishmaniasis can present as 3 main clinical variants: cutaneous, visceral, and mucocutaneous. Cutaneous leishmaniasis typically manifests as painless ulcers covered with hemorrhagic crusts on exposed regions of the body. While typically self-limited, lesions frequently result in irreversible scarring. Many Leishmania species respond well to antimonials such as sodium stibogluconate. Preventive measures include wearing protective clothing and sleeping inside insecticide-treated bed nets.5

Coxiella burnetii—Coxiella burnetii transmits through inhalation of aerosolized particles originating from the urine, feces, birth products, or milk of infected bovine. In 2003, a small number of cases were identified in US service members exposed to livestock while serving in Iraq.6 Outbreaks also occurred during World War II, but it is unclear whether they were caused by naturally occurring C burnetii or biowarfare.7 Though primarily a systemic illness with severe pneumonia, Q fever may manifest with an associated purpuric or morbilliform rash.8 Doxycycline is recommended both for treatment and empiric coverage.6

Acinetobacter baumannii—This multidrug-resistant organism is known to infect combat wounds and is associated with nosocomial outbreaks in military hospitals. Studies suggest environmental contamination and health care transmission contribute substantially to outbreaks in military hospitals.9 Cutaneous manifestations can include cellulitis with a peau d’orange appearance or necrotizing fasciitis; however, pneumonia and bacteremia have been reported. Prompt culture and antibiotic initiation with debridement are essential for treatment.10 Antibiotic stewardship and strict infection control are critical to prevent outbreaks and limit resistance.9

Africa

Plasmodium species—Malaria remains a life-threatening disease found in tropical and subtropical areas around the world. Despite preventive measures, 30 cases among US service members were reported in 2024.11 Cutaneous findings include purpura fulminans, petechiae, acral necrosis, or reticulated erythema.12 Service members stationed in endemic areas should take prophylactic antimalarials. Symptoms include fevers, headaches, and malaise, with possible rapid deterioration.13

Mycobacterium ulcerans—Mycobacterium ulcerans causes extensive necrotic ulcers—commonly known as Buruli ulcers—which generally begin as a nodule, plaque, papule, or edematous lesion, eventually progressing to extensive ulceration. Despite no documented cases of US personnel contracting Buruli ulcers, those stationed in endemic regions remain at risk. Environmental reservoirs of M ulcerans are unknown, but its DNA has been isolated from water sources.14,15 These ulcers take months to heal, making wound management and antimycobacterial therapy essential. Primary preventive measures include avoidance of swimming in rivers or agricultural work in endemic areas.14

Mpox Virus—During the 2022 mpox outbreak, male service members who engaged in sexual activity with other men were at the highest risk, with 88.8% of infected service members reporting this practice.16 While the virus is endemic to Africa, 89.0% of cases were reported from service members stationed in the United States.17 Typical infection results in fever, headache, lymphadenopathy, and myalgias, followed by a facial rash that spreads over the body, palms, and soles. Safe-sex practices help prevent transmission, and there is a vaccine available for high-risk patients.16

Southeast Asia

Leptospira species—Leptospira is an aerobic spirochete found in tropical regions worldwide. Transmission occurs when water contaminated with urine from infected animals exposes humans to the organism. Infection manifests as a mild febrile illness, though approximately 10% of patients develop Weil syndrome, consisting of conjunctival suffusion, jaundice, and acute kidney injury. Treatment and prophylaxis include doxycycline, but severe disease warrants intravenous antibiotics.17,18 A 2014 outbreak among Marines in Japan highlighted poor prophylactic compliance as a key risk factor.19 Proper education for those at risk is essential to prevent future outbreaks.

Mycobacterium leprae—Leprosy is an acid-fast mycobacterium that remains endemic in the Pacific Islands and Southeast Asia. Case reports of US service members diagnosed with leprosy exist, though only in patients who emigrated from endemic areas.20 This disease has a spectrum of manifestations depending on the immune response, with tuberculoid leprosy showing a ­cell-mediated (T helper 1) response and lepromatous leprosy having more of a humoral (T helper 2) response.21 It manifests with hypopigmented anesthetic macules and peripheral neuropathy. Diagnosis is made by skin biopsy, which shows perineural lymphohistiocytic inflammation and non-necrotizing granulomas.20 The infection typically is curable with a multidrug regimen.21

Strongyloides stercoralis—This nematode causes infection by transdermal penetration of bare feet. They then migrate to the lungs where the patient coughs and swallows the nematode into the gastrointestinal tract. Strongyloides stercoralis autoinfect by penetrating the intestinal wall, resulting in chronic digestive, respiratory, and cutaneous symptoms. Worldwide prevalence of S stercoralis infection is estimated to be 10% to 40%, with foreign-born US military members at increased risk compared to the general military population.22,23 Larva currens may manifest with a pruritic erythematous plaque at the site of penetration that progresses to an intensely pruritic, creeping dermatitis as the nematode migrates under the skin. Avoidance of barefoot soil exposure and treatment with ivermectin are effective preventive and therapeutic measures.23

South America

Ancylostoma braziliense—Found throughout the subtropical world, this hookworm primarily infects dogs and cats and is found in their stool. Larva currens has a similar manifestation and life cycle to cutaneous larva migrans, but autoinfection does not occur. Transmission occurs similarly to S stercoralis and responds well to oral albendazole or ivermectin; however, the infection is self-limited.24 Military cases have been reported,25 though overall morbidity remains poorly characterized.

Dengue Virus—An arbovirus transmitted by Aedes mosquitoes, dengue remains a major military threat. Service members in the Vietnam War experienced an attack rate as high as 80%.26,27 Infection often manifests with retro-orbital pain and a morbilliform rash that occurs 2 to 5 days after fever, though severe cases may progress to hemorrhagic dengue with skin petechiae or ecchymosis.28 Immediate intervention is essential in symptomatic patients to prevent life-threatening progression. There are no dengue vaccines approved by the US Food and Drug Administration for adults, thus military personnel in endemic areas remain at risk.27

Trypanosoma cruzi—Chagas disease is transmitted when a reduviid infected with T cruzi bites and defecates on the patient’s skin. A skin nodule (chagoma) or painless eyelid edema (Romaña sign) may appear at the site of parasite entry. Chronic disease may result in dilated cardiomyopathy.29 Several cases of Chagas disease have been reported in South American military operations, including an outbreak in 9 Columbian military personnel.30 Cases in the southwestern United States have recently emerged, emphasizing the need for increased awareness.31 Proper insect repellent helps to ward off reduviid bugs. Nifurtimox and benznidazole are the only drugs with proven efficacy against T cruzi.29

Continental United States of America

Coccidioides immitis—The first reported case of coccidiomycosis was described in 1892 in a service member with debilitating masses and ulcers.32 Endemic to arid regions of the western United States, coccidioidomycosis affects military trainees at rates up to 32% annually in high-risk settings.33 Primary infection occurs in the lungs and may spread hematologically. The fungi prefer dry desert soils, which may aerosolize during military maneuvers. Coccidioidomycosis occasionally causes erythema nodosum, and diffuse infection shows verrucous plaques, ulcers, or abscesses. Dust avoidance and mask wearing are advised for those in endemic regions. Ketoconazole and amphotericin B are the only treatments approved by the US Food and Drug Administration.32 When starting immunosuppressive drugs, clinicians should inquire if patients have previously been stationed in Coccidioides-endemic areas, such as Fort Irwin, California, to avoid reactivation of the fungi.33

Francisella tularensis—Acquired via ticks or contact with wild animals, tularemia causes an ulceroglandular disease with regional lymphadenopathy. Inoculation requires as few as 10 to 25 organisms; thus it is considered a Category A agent for bioterror.34 Natural outbreaks have occurred during war times, most recently during the civil wars in Bosnia and Kosovo.35 Patients may present with a painful ulcer that enlarges to form a plaque with raised borders. Personnel in wooded areas should use tick precautions and handle wild animals cautiously. Treatment includes gentamicin for severe disease, with tetracyclines effective in mild cases.34

PREVENTION AND MANAGEMENT STRATEGIES IN AUSTERE SETTINGS

For health care professionals practicing in military settings, austere environments can provide a challenge for diagnosis of neglected diseases. Despite a lack of advanced diagnostic tools, practical options can be applied to the diagnostic process; for example, teledermatology is utilized for treatment of service members deployed to remote environments.36

Management of uncommon infectious diseases in military personnel often requires treatments outside those practiced in domestic clinics. Field management may indicate prompt empiric therapy while balancing the risks of overtreatment against those of missed diagnoses37; however, medical evacuation to a higher level of care may be indicated in patients with severe presentations to expedite diagnosis and treatment.38

Prevention remains the primary goal to avoid local outbreaks. Long-sleeved uniforms, DEET (N, ­N-diethyl-meta-toluamide)–based repellents, permethrin-impregnated clothing, and bed nets are effective for vector protection. Prophylactic medications and vaccinations often are provided when personnel are deployed to endemic locations.39

Onsite entomology teams also can provide surveillance of the local insect populations. They may contribute to vector control through insecticide application and environmental modification. The Armed Forces Health Surveillance Division and the Global Emerging Infections Surveillance Program monitor infectious threats in real time to locate any potential outbreaks, guiding operational responses.40

FINAL THOUGHTS

Dermatologic signs often provide early evidence of infection in military personnel. With increasing antimicrobial resistance and the emergence of new pathogens, it is imperative for clinicians treating members of the military to recognize cutaneous signs, employ efficient diagnostic strategies, and encourage proactive prevention. A collaborative approach spanning dermatology, infectious disease, and public health is essential to protect the modern service member.

References
  1. Murray CK. Infectious disease complications of combat-related injuries. Crit Care Med. 2008;36(7 suppl):S358-S364. doi:10.1097/CCM.0b013e31817e2ffc
  2. Armed Forces Health Surveillance Division. AFHSD Annual Report. Defense Health Agency; 2023. Accessed March 5, 2026. https://www.health.mil/Reference-Center/Reports/2024/09/19/AFHSD-Annual-Report-2023
  3. Murray CK, Yun HC, Markelz AE, et al. Operation United Assistance: infectious disease threats to deployed military personnel. Military Medicine. 2015;180:626-651. doi:10.7205/MILMED-D-14-00691
  4. Niba Rawlings N, Bailey M, Courtenay O. Leishmaniasis in deployed military populations: a systematic review and meta-analysis. PLoS Negl Trop Dis. 2025;19:E0012680. doi:10.1371/journal.pntd.0012680
  5. de Vries HJC, Schallig HD. Cutaneous leishmaniasis: a 2022 updated narrative review into diagnosis and management developments. Am J Clin Dermatol. 2022;23:823-840. doi:10.1007/s40257-022-00726-8
  6. Anderson AD, Smoak B, Shuping E, et al. Q fever and the US military. Emerg Infect Dis. 2005;11:1320-1322. doi:10.3201/eid1108.050314
  7. Madariaga MG, Rezai K, Trenholme GM, et al. Q fever: a biological weapon in your backyard. Lancet Infect Dis. 2003;3:709-721. doi:10.1016/S1473-3099(03)00804-1
  8. Uribe Pulido N, Escorcia García C, Cabrera Orrego R, et al. Acute Q fever with dermatologic manifestations, molecular diagnosis, and no seroconversion. Open Forum Infect Dis. 2021;8:ofab458. doi:10.1093/ofid/ofab458
  9. Scott P, Deye G, Srinivasan A, et al. An outbreak of multidrug-resistant acinetobacter baumannii-calcoaceticus complex infection in the US Military Health Care System associated with military operations in Iraq. Clin Infect Dis. 2007;44:1577-1584. doi:10.1086/518170
  10. Guerrero DM, Perez F, Conger NG, et al. Acinetobacter baumannii-associated skin and soft tissue infections: recognizing a broadening spectrum of disease. Surg Infect (Larchmt). 2010;11:49-57. doi:10.1089/sur.2009.022
  11. Armed Forces Health Surveillance Division. Malaria among members of the US Armed Forces, 2024. MSMR. 2025;32:22-28.
  12. Farkouh CS, Abdi P, Amatul-Hadi F, et al. Cutaneous manifestations of malaria and their prognostic windows: a narrative review. Cureus. 2023;15:E41706. doi:10.7759/cureus.41706
  13. Shahbodaghi SD, Rathjen NA. Malaria: prevention, diagnosis, and treatment. Am Fam Physician. 2022;106:270-278.
  14. Yotsu RR, Suzuki K, Simmonds RE, et al. Buruli ulcer: a review of the current knowledge. Curr Trop Med Rep. 2018;5:247-256. doi:10.1007/s40475-018-0166-2
  15. Portaels F, Meyers WM, Ablordey A, et al. First cultivation and characterization of Mycobacterium ulcerans from the environment. PLoS Negl Trop Dis. 2008;2:E178. doi:10.1371/journal.pntd.0000178
  16. Metcalf-Kelly M, Garrison M, Stidham R. Characteristics of mpox cases diagnosed in Military Health System beneficiaries, May 2022-April 2024. MSMR. 2024;31:7-11.
  17. Rajapakse S. Leptospirosis: clinical aspects. Clin Med (Lond). 2022;22:14-17. doi:10.7861/clinmed.2021-0784
  18. Heath CW, Alexander AD, Galton MM. Leptospirosis in the United States: a of 483 cases in man, 1949–1961. N Engl J Med. 1965;273:857-864. doi:10.1056/NEJM196510142731606
  19. Mason V. Mystery outbreak investigation 2014—Leptospirosis licerasiae. November 17, 2017. Accessed March 5, 2026. https://usupulse.blogspot.com/2017/11/mystery-outbreak-investigation-2014.html
  20. Berjohn CM, DuPlessis CA, Tieu K, et al. Multibacillary leprosy in an active duty military member. Emerg Infect Dis. 2015;21:1077-1078. doi:10.3201/eid2106.141666
  21. Scollard DM, Adams LB, Gillis TP, et al. The continuing challenges of leprosy. Clin Microbiol Rev. 2006;19:338-381. doi:10.1128/CMR.19.2.338-381.2006
  22. Schär F, Trostdorf U, Giardina F, et al. Strongyloides stercoralis: global distribution and risk factors. PLoS Negl Trop Dis. 2013;7:E2288. doi:10.1371/journal.pntd.0002288
  23. Taheri B, Kuo HC, Hockenbury N, et al. Strongyloides stercoralis in the US Military Health System. Open Forum Infect Dis. 2023;10:ofad127. doi:10.1093/ofid/ofad127
  24. Bowman DD, Montgomery SP, Zajac AM, et al. Hookworms of dogs and cats as agents of cutaneous larva migrans. Trends Parasitol. 2010;26:162-167. doi:10.1016/j.pt.2010.01.005
  25. Inglis DM, Bailey MS. Unusual presentations of cutaneous larva migrans in British military personnel. BMJ Mil Health. 2023;169:E78-E81. doi:10.1136/bmjmilitary-2020-001677
  26. Halstead SB, Udomsakdi S, Singharaj P, et al. Dengue and chikungunya virus infection in man in Thailand, 1962–1964. 3. clinical, epidemiologic, and virologic observations on disease in non-indigenous white persons. Am J Trop Med Hyg. 1969;18:984-996. doi:10.4269/ajtmh.1969.18.984
  27. Gibbons RV, Streitz M, Babina T, et al. Dengue and US military operations from the Spanish-American War through today. Emerg Infect Dis. 2012;18:623-630. doi:10.3201/eid1804.110134
  28. Guzman MG, Harris E. Dengue. Lancet. 2015;385:453-465. doi:10.1016/S0140-6736(14)60572-9
  29. Bern C. Chagas’ disease. N Engl J Med. 2015;373:456-466. doi:10.1056/NEJMra1410150
  30. Vergara HD, Gómez CH, Faccini-Martínez ÁA, et al. Acute Chagas disease outbreak among military personnel, Colombia, 2021. Emerg Infect Dis. 2023;29:1882-1885. doi:10.3201/eid2909.230886
  31. Harris N, Woc-Colburn L, Gunter SM, et al. Autochthonous Chagas disease in the southern United States: a case report of suspected residential and military exposures. Zoonoses Public Health. 2017;64:491-493. doi:10.1111/zph.12360
  32. Crum NF. Coccidioidomycosis: a contemporary review. Infect Dis Ther. 2022;11:713-742. doi:10.1007/s40121-022-00606-y
  33. Crum NF, Potter M, Pappagianis D. Seroincidence of coccidioidomycosis during military desert training exercises. J Clin Microbiol. 2004;42:4552-4555. doi:10.1128/JCM.42.10.4552-4555.2004
  34. Antonello RM, Giacomelli A, Riccardi N. Tularemia for clinicians: an up-to-date review on epidemiology, diagnosis, prevention and treatment. Eur J Intern Med. 2025;135:25-32. doi:10.1016/j.ejim.2025.03.013
  35. Nelson CA, Sjöstedt A. Tularemia: a storied history, an ongoing threat. Clin Infect Dis. 2024;78(supplement_1):S1-S3. doi:10.1093/cid/ciad681
  36. Pendlebury GA, Roman J, Shrivastava V, et al. A call to action: evidence for the military integration of teledermoscopy in a pandemic era. Dermatopathology (Basel). 2022;9:327-342. doi:10.3390/dermatopathology9040039
  37. Bhagchandani R, Singhi S, Peter JV, et al. Tropical fevers: management guidelines. Indian J Crit Care Med. 2014;18:62-69. doi:10.4103/0972-5229.126074
  38. Joint Chiefs of Staff. Joint Publication 4-02: Joint Health Services. December 11, 2017. Accessed March 5, 2026. https://cdmrp.health.mil/pubs/pdf/Joint%20Health%20Services%20Publication%20JP%204-02.pdf
  39. Armed Services Pest Management Board. Technical Guide No. 36: Personal Protective Measures Against Insects and Other Arthropods of Military Significance. Updated November 2015. Accessed March 5, 2026. https://www.acq.osd.mil/eie/afpmb/docs/techguides/tg36.pdf
  40. Global Emerging Infections Surveillance. Armed Forces Health Surveillance Division Annual Report 2024. Defense Health Agency; 2024:15-28. Accessed March 17, 2026. https://www.health.mil/Reference-Center/Reports/2026/01/05/AFHSD-Annual-Report-2024
References
  1. Murray CK. Infectious disease complications of combat-related injuries. Crit Care Med. 2008;36(7 suppl):S358-S364. doi:10.1097/CCM.0b013e31817e2ffc
  2. Armed Forces Health Surveillance Division. AFHSD Annual Report. Defense Health Agency; 2023. Accessed March 5, 2026. https://www.health.mil/Reference-Center/Reports/2024/09/19/AFHSD-Annual-Report-2023
  3. Murray CK, Yun HC, Markelz AE, et al. Operation United Assistance: infectious disease threats to deployed military personnel. Military Medicine. 2015;180:626-651. doi:10.7205/MILMED-D-14-00691
  4. Niba Rawlings N, Bailey M, Courtenay O. Leishmaniasis in deployed military populations: a systematic review and meta-analysis. PLoS Negl Trop Dis. 2025;19:E0012680. doi:10.1371/journal.pntd.0012680
  5. de Vries HJC, Schallig HD. Cutaneous leishmaniasis: a 2022 updated narrative review into diagnosis and management developments. Am J Clin Dermatol. 2022;23:823-840. doi:10.1007/s40257-022-00726-8
  6. Anderson AD, Smoak B, Shuping E, et al. Q fever and the US military. Emerg Infect Dis. 2005;11:1320-1322. doi:10.3201/eid1108.050314
  7. Madariaga MG, Rezai K, Trenholme GM, et al. Q fever: a biological weapon in your backyard. Lancet Infect Dis. 2003;3:709-721. doi:10.1016/S1473-3099(03)00804-1
  8. Uribe Pulido N, Escorcia García C, Cabrera Orrego R, et al. Acute Q fever with dermatologic manifestations, molecular diagnosis, and no seroconversion. Open Forum Infect Dis. 2021;8:ofab458. doi:10.1093/ofid/ofab458
  9. Scott P, Deye G, Srinivasan A, et al. An outbreak of multidrug-resistant acinetobacter baumannii-calcoaceticus complex infection in the US Military Health Care System associated with military operations in Iraq. Clin Infect Dis. 2007;44:1577-1584. doi:10.1086/518170
  10. Guerrero DM, Perez F, Conger NG, et al. Acinetobacter baumannii-associated skin and soft tissue infections: recognizing a broadening spectrum of disease. Surg Infect (Larchmt). 2010;11:49-57. doi:10.1089/sur.2009.022
  11. Armed Forces Health Surveillance Division. Malaria among members of the US Armed Forces, 2024. MSMR. 2025;32:22-28.
  12. Farkouh CS, Abdi P, Amatul-Hadi F, et al. Cutaneous manifestations of malaria and their prognostic windows: a narrative review. Cureus. 2023;15:E41706. doi:10.7759/cureus.41706
  13. Shahbodaghi SD, Rathjen NA. Malaria: prevention, diagnosis, and treatment. Am Fam Physician. 2022;106:270-278.
  14. Yotsu RR, Suzuki K, Simmonds RE, et al. Buruli ulcer: a review of the current knowledge. Curr Trop Med Rep. 2018;5:247-256. doi:10.1007/s40475-018-0166-2
  15. Portaels F, Meyers WM, Ablordey A, et al. First cultivation and characterization of Mycobacterium ulcerans from the environment. PLoS Negl Trop Dis. 2008;2:E178. doi:10.1371/journal.pntd.0000178
  16. Metcalf-Kelly M, Garrison M, Stidham R. Characteristics of mpox cases diagnosed in Military Health System beneficiaries, May 2022-April 2024. MSMR. 2024;31:7-11.
  17. Rajapakse S. Leptospirosis: clinical aspects. Clin Med (Lond). 2022;22:14-17. doi:10.7861/clinmed.2021-0784
  18. Heath CW, Alexander AD, Galton MM. Leptospirosis in the United States: a of 483 cases in man, 1949–1961. N Engl J Med. 1965;273:857-864. doi:10.1056/NEJM196510142731606
  19. Mason V. Mystery outbreak investigation 2014—Leptospirosis licerasiae. November 17, 2017. Accessed March 5, 2026. https://usupulse.blogspot.com/2017/11/mystery-outbreak-investigation-2014.html
  20. Berjohn CM, DuPlessis CA, Tieu K, et al. Multibacillary leprosy in an active duty military member. Emerg Infect Dis. 2015;21:1077-1078. doi:10.3201/eid2106.141666
  21. Scollard DM, Adams LB, Gillis TP, et al. The continuing challenges of leprosy. Clin Microbiol Rev. 2006;19:338-381. doi:10.1128/CMR.19.2.338-381.2006
  22. Schär F, Trostdorf U, Giardina F, et al. Strongyloides stercoralis: global distribution and risk factors. PLoS Negl Trop Dis. 2013;7:E2288. doi:10.1371/journal.pntd.0002288
  23. Taheri B, Kuo HC, Hockenbury N, et al. Strongyloides stercoralis in the US Military Health System. Open Forum Infect Dis. 2023;10:ofad127. doi:10.1093/ofid/ofad127
  24. Bowman DD, Montgomery SP, Zajac AM, et al. Hookworms of dogs and cats as agents of cutaneous larva migrans. Trends Parasitol. 2010;26:162-167. doi:10.1016/j.pt.2010.01.005
  25. Inglis DM, Bailey MS. Unusual presentations of cutaneous larva migrans in British military personnel. BMJ Mil Health. 2023;169:E78-E81. doi:10.1136/bmjmilitary-2020-001677
  26. Halstead SB, Udomsakdi S, Singharaj P, et al. Dengue and chikungunya virus infection in man in Thailand, 1962–1964. 3. clinical, epidemiologic, and virologic observations on disease in non-indigenous white persons. Am J Trop Med Hyg. 1969;18:984-996. doi:10.4269/ajtmh.1969.18.984
  27. Gibbons RV, Streitz M, Babina T, et al. Dengue and US military operations from the Spanish-American War through today. Emerg Infect Dis. 2012;18:623-630. doi:10.3201/eid1804.110134
  28. Guzman MG, Harris E. Dengue. Lancet. 2015;385:453-465. doi:10.1016/S0140-6736(14)60572-9
  29. Bern C. Chagas’ disease. N Engl J Med. 2015;373:456-466. doi:10.1056/NEJMra1410150
  30. Vergara HD, Gómez CH, Faccini-Martínez ÁA, et al. Acute Chagas disease outbreak among military personnel, Colombia, 2021. Emerg Infect Dis. 2023;29:1882-1885. doi:10.3201/eid2909.230886
  31. Harris N, Woc-Colburn L, Gunter SM, et al. Autochthonous Chagas disease in the southern United States: a case report of suspected residential and military exposures. Zoonoses Public Health. 2017;64:491-493. doi:10.1111/zph.12360
  32. Crum NF. Coccidioidomycosis: a contemporary review. Infect Dis Ther. 2022;11:713-742. doi:10.1007/s40121-022-00606-y
  33. Crum NF, Potter M, Pappagianis D. Seroincidence of coccidioidomycosis during military desert training exercises. J Clin Microbiol. 2004;42:4552-4555. doi:10.1128/JCM.42.10.4552-4555.2004
  34. Antonello RM, Giacomelli A, Riccardi N. Tularemia for clinicians: an up-to-date review on epidemiology, diagnosis, prevention and treatment. Eur J Intern Med. 2025;135:25-32. doi:10.1016/j.ejim.2025.03.013
  35. Nelson CA, Sjöstedt A. Tularemia: a storied history, an ongoing threat. Clin Infect Dis. 2024;78(supplement_1):S1-S3. doi:10.1093/cid/ciad681
  36. Pendlebury GA, Roman J, Shrivastava V, et al. A call to action: evidence for the military integration of teledermoscopy in a pandemic era. Dermatopathology (Basel). 2022;9:327-342. doi:10.3390/dermatopathology9040039
  37. Bhagchandani R, Singhi S, Peter JV, et al. Tropical fevers: management guidelines. Indian J Crit Care Med. 2014;18:62-69. doi:10.4103/0972-5229.126074
  38. Joint Chiefs of Staff. Joint Publication 4-02: Joint Health Services. December 11, 2017. Accessed March 5, 2026. https://cdmrp.health.mil/pubs/pdf/Joint%20Health%20Services%20Publication%20JP%204-02.pdf
  39. Armed Services Pest Management Board. Technical Guide No. 36: Personal Protective Measures Against Insects and Other Arthropods of Military Significance. Updated November 2015. Accessed March 5, 2026. https://www.acq.osd.mil/eie/afpmb/docs/techguides/tg36.pdf
  40. Global Emerging Infections Surveillance. Armed Forces Health Surveillance Division Annual Report 2024. Defense Health Agency; 2024:15-28. Accessed March 17, 2026. https://www.health.mil/Reference-Center/Reports/2026/01/05/AFHSD-Annual-Report-2024
Issue
Cutis - 117(4)
Issue
Cutis - 117(4)
Page Number
118-121
Page Number
118-121
Publications
Cutis
MDedge Dermatology
Publications
Cutis
MDedge Dermatology
Topics
Infectious Diseases
Article Type
Article
Display Headline

Cutaneous Manifestations of Neglected Infectious Diseases in US Military Personnel

Display Headline

Cutaneous Manifestations of Neglected Infectious Diseases in US Military Personnel

Sections
Military Dermatology
Inside the Article

Practice Points

  • Military personnel stationed overseas are at risk for encountering infectious organisms that are not regularly observed domestically—many of which have cutaneous manifestations.
  • Health care professionals treating military personnel should consider uncommonly encountered infections in the differential diagnosis for certain dermatologic presentations.
  • Clinicians should inquire if patients have been stationed in Coccidioides immitis–endemic areas prior to the initiation of immunosuppression.
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Gate On Date
Un-Gate On Date
Use ProPublica
CFC Schedule Remove Status
Hide sidebar & use full width
render the right sidebar.
Conference Recap Checkbox
Not Conference Recap
Clinical Edge
Display the Slideshow in this Article
Medscape Article
Display survey writer
Reuters content
Disable Inline Native ads
WebMD Article
survey writer start date
Teaser Media
CT117004118-300x300
Subscribe to Guilherme Kuceki, MD